Lexeo Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lexeo Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2022 to 2023.
  • Lexeo Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.05M, a 1145% increase year-over-year.
  • Lexeo Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $6.76M.
  • Lexeo Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $2.12M, a 72% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.